New Hope for Cats with HCM
Felycin ca1 is a newly approved to treat cats with subclinical HCM. In the paper linked below, the authors of the study show that the thickness of the heart wall were significantly lower in the group who received the drug than in the group who received a placebo (didn’t get the drug), indicating the use of this drug in delying the progression of HCM in cats. In addition, the drug was well-tolerated by the cats in the study.
This is big news since it is the first medication that can be given to cats before they develop significant symptoms.
Read the article:
